Avanos Medical
(NYSE) AVNS
Avanos Medical Financials at a Glance
Market Cap
$648.72M
Revenue (TTM)
$701.20M
Net Income (TTM)
$67.90M
EPS (TTM)
$-1.58
P/E Ratio
-8.85
Dividend
$0.00
Beta (Volatility)
0.89 (Low)
Dividend
$0.00
Beta (Volatility)
0.89 (Low)
Price
$13.95
Volume
11,969
Open
$13.83
Price
$13.95
Volume
11,969
Open
$13.83
Previous Close
$13.95
Daily Range
$13.83 - $14.23
52-Week Range
$9.30 - $15.68
Dividend
$0.00
Beta (Volatility)
0.89 (Low)
Price
$13.95
Volume
11,969
Open
$13.83
Previous Close
$13.95
Daily Range
$13.83 - $14.23
52-Week Range
$9.30 - $15.68
AVNS News
AVNS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Avanos Medical
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
2,287
CEO
David C. Pacitti, MBA
Website
www.avanos.comHeadquarters
Alpharetta, GA 30004, US
AVNS Financials
Key Financial Metrics (TTM)
Gross Margin
50%
Operating Margin
-9%
Net Income Margin
-10%
Return on Equity
-9%
Return on Capital
-7%
Return on Assets
-6%
Earnings Yield
-11.30%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$648.72M
Shares Outstanding
46.50M
Volume
11.97K
Short Interest
0.00%
Avg. Volume
595.05K
Financials (TTM)
Gross Profit
$349.00M
Operating Income
$61.60M
EBITDA
$33.20M
Operating Cash Flow
$74.70M
Capital Expenditure
$31.60M
Free Cash Flow
$43.10M
Cash & ST Invst.
$89.80M
Total Debt
$129.10M
Avanos Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$180.90M
+0.7%
Gross Profit
$86.00M
-13.4%
Gross Margin
47.54%
N/A
Market Cap
$648.72M
N/A
Market Cap/Employee
$291.30K
N/A
Employees
2,227
N/A
Net Income
$3.70M
+100.9%
EBITDA
$13.00M
+103.2%
Quarterly Fundamentals
Net Cash
$39.30M
+37.1%
Accounts Receivable
$103.80M
-21.8%
Inventory
$148.00M
+6.6%
Long Term Debt
$110.70M
-26.2%
Short Term Debt
$18.40M
-9.4%
Return on Assets
-6.32%
N/A
Return on Invested Capital
-6.78%
N/A
Free Cash Flow
$21.30M
-59.9%
Operating Cash Flow
$28.20M
-51.3%